Zenas BioPharma Statistics
NASDAQ: ZBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
26.24-1.94 (-6.88%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 26.24 0.00%
Zenas BioPharma by the numbers
Zenas BioPharma has a market capitalization of $1.71 billion based on 65.18M shares outstanding. With trailing EPS of $-9.63, Zenas BioPharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.3% below its 50-day average and 4.3% above its 200-day average.
Average daily trading volume is 735.12K shares, or about $19.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ZBIO valuation vs. peer median
| Metric | ZBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.71B | $1.82B | -6% |
| Avg. volume | 735.12K | 1.17M | -37% |
Peer median across 8 companies: GPCR, TRVI, XNCR, XERS, ZYME, URGN, BHVN, GENB.
Valuation
- Market cap
- $1.71B
- EPS (TTM)
- $-9.63
- Shares outstanding
- 65.18M
Price and trading
- Previous close
- 28.18
- Open
- 27.79
- Day range
- 25.51 – 27.98
- 52-week range
- 13.50 – 44.60
- 52-week change
- +35.16%
- Beta
- —
- Volume
- 557.41K
- Average volume
- 735.12K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 1.71B
- Forward Pe
- -5.63
- Eps
- -9.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 44.60
- Week52 Low
- 13.50
- Avg Volume
- 735.12K
- Shares Outstanding
- 65.18M
- Ma50
- 30.97
- Ma200
- 25.15
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -41.17%
- Pct From52w Low
- 94.37%